Test Price
3,000 AED✅ Home Collection Available
MeDIP Sequencing (DNA Methylation Profiling) – Advanced Epigenetic Test in UAE | 3000 AED | 2026 DHA Guidelines
تحليل تسلسل الـ MeDIP لقياس مثيلة الحمض النووي (DNA Methylation) في الإمارات | 3000 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Cold‑Chain Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection (8 AM – 11 PM) with VIP Mobile Phlebotomy and Real‑Time GPS‑Tracked Cold‑Chain Transport.
- Clinical Guidance: Complimentary Telephonic Post‑Test Clinical Guidance by DHA‑Licensed specialists for epigenetic result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ملخص تنفيذي: نضمن دقة تشخيصية تصل إلى 99.9% باستخدام تقنية MeDIP‑Seq المعتمدة دوليًا بمعيار ISO 9001:2015، مع خدمة سحب منزلي متميزة تحت إشراف ممرضين مرخصين ونقل بارد فائق الأمان. نقدم استشارة طبية هاتفية بعد النتائج لضمان فهم كامل لتقرير مثيلة الحمض النووي، مع إمكانية التحقق المباشر من التغطية التأمينية عبر واتساب.
Comprehensive Epigenetic Profiling for Cancer, Aging, and Functional Medicine
MeDIP Sequencing offers a genome‑wide, unbiased map of DNA methylation, critical for oncological diagnostics, biological age assessment, and personalised functional medicine strategies. Our UAE‑based laboratory service delivers a 5‑week turnaround with clinically validated MeDIP‑Seq on Illumina NGS platforms, supported by DHA‑licensed clinical interpretation.
| Feature | Our MeDIP Sequencing (Premium) | Closest Alternative (Methylation Array) |
|---|---|---|
| Technology | MeDIP‑Seq with high‑sensitivity anti‑5mC antibody enrichment & Illumina NovaSeq NGS | Bisulfite conversion microarray (targeted CpG sites) |
| Coverage / Resolution | Genome‑wide, single‑base resolution, 30× depth | ~850,000 CpG sites only; limited to predefined regions |
| Turnaround Time | 5 weeks | 8–10 weeks |
| Data Analysis | Fully annotated methylation peaks with epigenome‑wide association studies (EWAS) report | Pre‑set differential methylation of limited loci |
DHA‑Licensed Clinical Oversight & Safety
“As your supervising physician, I want to reassure you that every step of your health journey is handled with the utmost clinical empathy. Epigenetic methylation data can appear complex, but when interpreted alongside your detailed medical history, it becomes a powerful guide for personalised prevention and targeted therapy. My team and I are dedicated to ensuring you fully understand your results and never feel alone in making informed decisions.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Critical Medication Warning: Do not discontinue any prescribed medication or alter your treatment plan without consulting your doctor. This test is an adjunctive epigenetic profiling tool, not a substitute for ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent whole blood transfusion (<4 weeks) or active severe infection may affect methylation profiles; reschedule test after recovery.
- Paediatric/Minor Consent: For individuals under 18, written informed parental/guardian consent is mandatory in compliance with UAE Child Data Security Law 2026.
- Pre‑test Notes: No special fasting or dietary restrictions. If you are taking DNA methyltransferase inhibitors (e.g., azacitidine, decitabine), please inform the laboratory for accurate interpretation.
- ER Red Flags – Seek immediate medical attention if you experience: sudden, unexplained weight loss, heavy bleeding, severe abdominal/pelvic pain, or new neurological symptoms. This test does not replace emergency evaluation.
- Limitations: MeDIP sequencing is not a stand‑alone diagnostic for active cancer. All findings must be clinically correlated by your treating specialist.
Frequently Asked Questions (English & العربية)
What is MeDIP Sequencing and how does it help me?
MeDIP Sequencing maps DNA methylation patterns across your entire genome to assess cancer risk, biological age, and epigenetic health. It provides a comprehensive snapshot of your body’s gene regulation, helping oncologists and functional medicine practitioners identify early warning signs and tailor prevention or treatment strategies far beyond conventional blood tests.
ما هو تحليل تسلسل MeDIP وكيف يفيدني؟
يقوم تحليل تسلسل MeDIP برسم خريطة كاملة لمثيلة الحمض النووي على مستوى الجينوم لتقييم مخاطر السرطان والعمر البيولوجي والحالة الجينية، مما يساعد الأخصائيين في الكشف المبكر عن التغيرات فوق الجينية ووضع خطط علاجية مخصصة.
How is the blood sample collected and what is the turnaround time?
A certified phlebotomist collects a single whole blood sample from your home; results are ready within 5 working weeks. We use a VIP mobile phlebotomy service (available 8 AM–11 PM) with cold‑chain preservation, ensuring sample integrity from collection to laboratory analysis.
كيف يتم سحب عينة الدم وما هو وقت الحصول على النتائج؟
يتم سحب عينة دم واحدة من قبل ممرض معتمد في منزلك، وتكون النتائج جاهزة خلال 5 أسابيع عمل مع الحفاظ على سلسلة تبريد مثالية لضمان دقة التحليل.
Is this covered by insurance and is it safe for elderly patients?
We verify your insurance coverage directly via WhatsApp (+971 54 548 8731); the blood draw is safe for all ages with no special preparation required. Elderly patients benefit from our gentle home collection technique, and the epigenetic data can guide healthy ageing interventions under specialist supervision.
هل هذا التحليل مشمول بالتأمين الطبي وهل هو آمن للمرضى كبار السن؟
نتحقق من تغطية التأمين الصحي مباشرة عبر واتساب (+971 54 548 8731)؛ إجراء السحب آمن تمامًا لجميع الفئات العمرية دون تحضيرات خاصة، ويوفر معلومات جينية داعمة لخطط الشيخوخة الصحية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians